[Ip-health] industry support for drug reviews
Aidan Hollis
ahollis@ucalgary.ca
Mon Oct 16 15:08:01 2006
This is a multi-part message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
The BMJ has a study comparing industry-funded drug reviews with Cochrane re=
views.
extract:
"Compared with industry supported reviews and reviews with undeclared suppo=
rt, Cochrane reviews had more often considered the potential for bias in th=
e review-for example, by describing the method of concealment of allocation=
and describing excluded patients or studies. The seven industry supported =
reviews that had conclusions recommended the experimental drug without rese=
rvations, compared with none of the Cochrane reviews, although the estimate=
d treatment effect was similar on average. Reviews with undeclared support =
and reviews with not for profit support or no support had conclusions that =
were similar in cautiousness to the Cochrane reviews. "
Full text available at:
http://bmj.bmjjournals.com/cgi/content/full/333/7572/782
Aidan Hollis
Associate Professor
Department of Economics
University of Calgary
2500 University Dr NW
Calgary Alberta
T2N 1N4 Canada
tel: 403 220 5861 fax: 403 220 5861
email: ahollis@ucalgary.ca
web: http://econ.ucalgary.ca/hollis.htm
--